DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lencioni R, Zou JM, Leberre M , et al.
Sorafenib (SOR) or placebo (PL) in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma: Phase II, randomized, double-blind SPACE trial.
J Clin Oncol 2012;
30 (Suppl. 04) Abstract LBA154
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.